Skip to main content
. 2021 Jun 7;22(11):6142. doi: 10.3390/ijms22116142

Figure 1.

Figure 1

Impact of timed daily bromocriptine (at ZT 13 or ZT 19) or control treatment for 16 days on markers of vascular pathology. *—p < 0.05, 2-sided t-test; NS—not significant.